Keyphrases
BACH1
100%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
89%
DYRK2
75%
Heat Shock Factor 1 (HSF1)
53%
NFE2L2
50%
Transcription Factor
47%
Cannabidiol
37%
In Cancer
35%
Poor Prognosis
30%
Proteotoxic Stress
28%
Cancer Progression
28%
Two-level
28%
Methyl
25%
Air Pollutants
25%
CDDO-Me
25%
Antioxidant Response
25%
Bioactivation
25%
Cell Division Cycle 25A
25%
Human Lung Cells
25%
Regulatory Switch
25%
3-Nitrobenzanthrone
25%
Isomeric
25%
Antiviral Pathways
25%
Colorectal Cancer Patients
25%
AT9283
25%
Oncolytic Virotherapy
25%
Stress-responsive
25%
Keratinocytes
25%
Sulforaphane
25%
Inflammatory Pathways
25%
Isothiocyanates
25%
Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A
25%
Kinase Inhibitor
25%
Natural Triterpenoids
25%
Mammalian Target of Rapamycin (mTOR)
25%
Dimethyl Itaconate
25%
Antioxidant Pathway
25%
Acetylenic
25%
Dual Inhibition
25%
Biotinylation
25%
Multi-target
25%
Cancer Cells
17%
Therapeutic Outcome
16%
Heme oxygenase-1 (HO-1)
14%
Triple-negative Breast Cancer
11%
Tumor
11%
CDDO Derivatives
10%
Degrader
9%
Oxidative Inflammation
8%
Oxidative Stress
8%
Neurodegenerative Diseases
8%
Huntington's Disease
8%
Chemical Derivatives
8%
Heterogeneity in Responses
8%
Tumor Organoids
8%
Tumor Slices
8%
Antiviral Response
8%
Viral Spread
8%
Patient-derived
8%
Anticancer Therapeutics
8%
Type I IFN
8%
Cancer Cell Lines
8%
Treatment Failure
8%
Brain Tumor
8%
Keap1-Nrf2
8%
Cysteine Residues
8%
Three-dimensional (3D)
8%
Itaconate
8%
Resistant Cancer Cells
8%
Antiviral Immunity
8%
Organotypic
8%
Krebs Cycle
8%
Clinical Efficacy
8%
Colon Tumor
8%
Tumor Model
8%
Colon
8%
NF-B
8%
Oncolytic Virus
8%
Cas9 Protein
7%
Proteostasis
7%
HSF1 Inhibitors
7%
Transcriptional Repressor
7%
Antioxidant Properties
6%
Phytocannabinoids
6%
Triple-negative Breast Cancer Cells
6%
Apoptosis
5%
Putative Drug Targets
5%
Patient Prognosis
5%
Colorectal Tumor
5%
Hyperactivity
5%
Aurora Kinase Inhibitor
5%
26S Proteasome
5%
Therapeutic Target
5%
Stress Response Pathway
5%
Nuclear Factor-erythroid 2 p45-related Factor 2
5%
Transcriptional Activity
5%
Nuclear Stability
5%
A549
5%
In(III)
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antioxidant
76%
Malignant Neoplasm
67%
Prothrombin
52%
Cannabidiol
37%
Proteasome
33%
Inflammation
30%
3 Nitrobenzanthrone
25%
Isothiocyanate
25%
Bardoxolone Methyl
25%
Cannabidiol Derivative
25%
Bardoxolone
25%
Mammalian Target of Rapamycin
25%
Sulforaphane
25%
1 Cyclopropyl 3 [3 (5 Morpholinomethyl 1h Benzimidazol 2 Yl) 1h Pyrazol 4 Yl]urea
25%
Bioactivation
25%
Cycline
25%
Cyclin Dependent Kinase
25%
Triterpenoid
25%
Colorectal Cancer
25%
Ubiquitin Protein Ligase E3
25%
Ubiquitin
25%
Transcription Factor NF E2 P45 Subunit
25%
Phosphatase
25%
Phosphotransferase Inhibitor
25%
Protein Serine Threonine Kinase
25%
Virotherapy
25%
Antivirus Agent
25%
Itaconic Acid
25%
Degenerative Disease
25%
Neuroprotective Agent
25%
Breast Cancer
20%
Transcription Factors
19%
Neoplasm
17%
Lung Cancer
14%
Anti-Inflammatory Drug
14%
Neuroprotection
12%
Antiinflammatory Activity
12%
Huntington Chorea
12%
Multiple Sclerosis
12%
Alzheimer's Disease
12%
Heme Oxygenase 1
12%
Phosphotransferase
10%
Heat Shock Transcription Factor 1
8%
Hemin
8%
Ligase
8%
Colon Tumor
6%
Tumor Model
6%
Brain Tumor
6%
Cysteine
6%
Oncolytic Virus
6%
Aurora Kinase Inhibitor
5%
Colorectal Tumor
5%
Biochemistry, Genetics and Molecular Biology
Kinase
84%
Phosphotransferase
84%
Cancer Cell
59%
Heat Shock Transcription Factor 1
50%
Colon
37%
Proteasome
29%
Protein Homeostasis
27%
Isothiocyanate
25%
HSF1
25%
Mechanistic Target of Rapamycin
25%
Dual-Specificity Kinase
25%
Tyrosine
25%
Tumor Suppressor Protein
25%
Sulforaphane
25%
Anticancer
25%
Metabolite
25%
Cell Survival
25%
Cell Cycle
25%
Oncogene C Myc
12%
Aurora Kinase
12%
Small Molecule
12%
Protein Folding
12%
P53
12%
Antineoplastic Activity
12%
Citric Acid Cycle
12%
Krebs Cycle
12%
KEAP1
12%
Cysteine
12%
Transcription Factors
8%
CRISPR/Cas9
8%
Computer Model
6%
Genetics
6%